搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 1 小时
时间不限
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
经济参考网
1 分钟
新华健康|康方生物自主研发创新药获批新适应症
近日,国家药品监督管理局官网显示,康方生物自主研发的一款创新抗癌PD-1/CTLA-4双特异性抗体开坦尼(卡度尼利单抗注射液)正式获批上市,用于与含氟尿嘧啶类和铂类药物化疗联合治疗局部晚期不可切除或转移性胃或胃食管结合部腺癌患者。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Approves elimination of NLI
Files suit against accuser
Announces retirement
Top colleges hit with lawsuit
$273M Helene relief bill
To settle FTC charges
AZ Senate debate takeaways
Fat Bear Week winner
Russian arms depot struck
Rare comet in October
Monet painting returned
Increases heart attack risk?
Idaho murder trial delayed
273 'noncitizens' removed
Walz on Electoral College
Meat, poultry items recalled
Judge tosses New York law
SCOTUS hears appeal
Mets advance to NLCS
3% HS students transgender
Speaks with Netanyahu
Ex-AR deputy sentenced
GSK to settle 80K lawsuits
Campaign, groups raise $1B
Ukraine meeting postponed
US warns of solar storm
Pilot's death forces landing
Faces $3B in penalties
Georgia election board sued
反馈